Lv12
30 积分 2025-09-29 加入
Patient‐reported outcomes of a phase II neoadjuvant apalutamide (ARN‐509) and radical prostatectomy in treatment of intermediate‐ to high‐risk prostate cancer (NEAR) trial
1小时前
待确认
ARNEO: A Randomized Phase II Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer
1天前
已完结
[Expert consensus on endocrine therapy of breast cancer (2023 edition)]
1个月前
已完结
[Chinese multidisciplinary expert consensus on combined immunotherapy for hepatocellular carcinoma(2023 version)]
2个月前
已完结
Biopsychosocial Characteristics of Community‐Dwelling Older Adults with Limited Ability to Walk One‐Quarter of a Mile
2个月前
已关闭
Expert Consensus on the Clinical Application of PI3K/AKT/mTOR Inhibitors in the Treatment of Breast Cancer (2025 Edition)
2个月前
已完结
[Expert consensus on the clinical application of PI3K/AKT/mTOR inhibitors in the treatment of advanced breast cancer]
2个月前
已完结
[Expert consensus on the clinical application of PI3K/AKT/mTOR inhibitors in the treatment of advanced breast cancer]
2个月前
已完结
皖公网安备34019202002308
